Kastus Showcases Superbug-Killing Antimicrobial Solutions
By HospiMedica International staff writers Posted on 01 Feb 2017 |
Irish technology firm Kastus Technologies, a provider of antimicrobial coating and additive to help reduce the spread of antibiotic resistant infections, showcased its novel and patented technology at Arab Health 2017, the largest healthcare exhibition in the Middle East.
It is estimated that superbugs could kill 10 million people worldwide every year by 2050. In order to address this problem, Kastus has developed an antimicrobial solution that kills micro-organisms or inhibits their growth and can be used on any paint, plastic, ceramic and glass surfaces. The technology can be used to protect a range of everyday surfaces – from smartphones to door handles – against deadly bacteria, including MRSA and E.coli.
The two products showcased by the Irish company at the 42nd Arab Health Exhibition & Congress 2017 were Log4+ and KASTUS Paints. Log4+ is a novel, patented, visible light activated (VLA) photocatalytic antimicrobial coating for glass and ceramic. Visible light and oxygen in contact with Log4+ triggers a chemical reaction, resulting in the decomposition of organic and inorganic substances and offering bacteria kill rates of up to 99.99%. Log4+ is effective in indoor lighting conditions, not requiring UV. Since its is sintered into the glass or ceramic surface at high temperature, Log4+ is permanent, long lasting, scratch resistant and invisible.
KASTUS Paints is a novel antimicrobial additive that has been designed to be added to paint as a powder, offering bacteria kill rates of up to 99.99%. KASTUS Paints is an active ingredient–reservoir material, which can be added to the mix of ingredients in the manufacture of paints to give them enhanced antimicrobial properties. The active ingredient–reservoir particles diffuse through to the surface of the paint coating and the bound active ingredients are held close to the coating surface, resulting in the release of an enhanced level of antibacterial material.
Founder and CEO of the company John Browne said, “The uniqueness of antimicrobial surface treatment means that real world applications are endless with global commercial appeal. We have already achieved excellent results in trials with several international customers who have been searching for such a solution for years. The plan is supply customers in the electronics and healthcare sectors in 2017.”
It is estimated that superbugs could kill 10 million people worldwide every year by 2050. In order to address this problem, Kastus has developed an antimicrobial solution that kills micro-organisms or inhibits their growth and can be used on any paint, plastic, ceramic and glass surfaces. The technology can be used to protect a range of everyday surfaces – from smartphones to door handles – against deadly bacteria, including MRSA and E.coli.
The two products showcased by the Irish company at the 42nd Arab Health Exhibition & Congress 2017 were Log4+ and KASTUS Paints. Log4+ is a novel, patented, visible light activated (VLA) photocatalytic antimicrobial coating for glass and ceramic. Visible light and oxygen in contact with Log4+ triggers a chemical reaction, resulting in the decomposition of organic and inorganic substances and offering bacteria kill rates of up to 99.99%. Log4+ is effective in indoor lighting conditions, not requiring UV. Since its is sintered into the glass or ceramic surface at high temperature, Log4+ is permanent, long lasting, scratch resistant and invisible.
KASTUS Paints is a novel antimicrobial additive that has been designed to be added to paint as a powder, offering bacteria kill rates of up to 99.99%. KASTUS Paints is an active ingredient–reservoir material, which can be added to the mix of ingredients in the manufacture of paints to give them enhanced antimicrobial properties. The active ingredient–reservoir particles diffuse through to the surface of the paint coating and the bound active ingredients are held close to the coating surface, resulting in the release of an enhanced level of antibacterial material.
Founder and CEO of the company John Browne said, “The uniqueness of antimicrobial surface treatment means that real world applications are endless with global commercial appeal. We have already achieved excellent results in trials with several international customers who have been searching for such a solution for years. The plan is supply customers in the electronics and healthcare sectors in 2017.”
Latest ARAB HEALTH 2017 News
- Dräger Introduces New Incubator and Baby Warmer
- Esaote Presents New Ultrasound Platform at Arab Health 2017
- Merivaara Showcases Q-Flow Surgical Light at Arab Health
- Rober Showcases Pressure Ulcer Protection for Critically Ill Patients
- Finland Showcases Cutting-Edge Health Services and Technologies
- US Medical Leaders Build on Professional Partnerships at Arab Health 2017
- Rostec Presents Newborn Care Technologies
- Ascom Unveils Nurse Call Innovations
- Mediplus Launches IV Drug Delivery System at Arab Health Show
- UK Pavilion Performs Groundbreaking Surgery at Dubai Trade Show
- ZOLL Showcases Expanded Portfolio of Products at Arab Health 2017
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more